NEU

NEUREN PHARMACEUT.

• The Motley Fool·4h ago

  Is this battered ASX biotech stock ready to rocket higher?

• The Motley Fool·1d ago

  Why Neuren shares are rebounding on Wednesday after a brutal 2026 sell-off

• ASX·03/26 06:50

  Notification of cessation of securities - NEU

• ASX·03/23 21:41

  Update - Notification of buy-back - NEU

• ASX·03/16 00:00

  Code Of Conduct

• ASX·03/12 21:27

  Update - Notification of buy-back - NEU

• The Motley Fool·03/10 05:59

  Here are the top 10 ASX 200 shares today

• ASX·03/09 21:42

  Update - Notification of buy-back - NEU

• ASX·03/06 00:00

  Director Conflict Of Interest Policy

• ASX·03/05 23:27

  Change of Director's Interest Notice - J Basile

• The Motley Fool·03/05 04:14

  Why this cheap ASX 200 stock could rise 80%

• The Motley Fool·03/03 23:09

  Macquarie thinks this biotech company's shares could jump more than 50%

• Dow Jones·03/03 22:09

  *Neuren Pharmaceuticals Target Price Cut 9.9% to A$19.10/Share by Macquarie>NEU.AU

• ASX·03/03 21:45

  Update - Notification of buy-back - NEU

• The Motley Fool·03/03 02:46

  Why Capstone Copper, Life360, Neuren, and St George Mining shares are falling today